QT
AQST icon

Quantbot Technologies’s Aquestive Therapeutics AQST Stock Holding History

Quantbot Technologies’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$98.6K Sell
23,707
-79,739
-77% -$336K ﹤0.01% 1470
2026
Q1 		$429K Buy
103,446
+84,985
+460% +$345K 0.02% 911
2025
Q4 		$119K Sell
18,461
-14,746
-44% -$91.9K ﹤0.01% 1379
2025
Q3 		$186K Buy
+33,207
New +$144K 0.01% 1317
2025
Q2 		– Sell
-851
Closed -$2.47K – 1616
2025
Q1 		$2.47K Buy
+851
New +$2.58K ﹤0.01% 1400
2024
Q4 		– Sell
-27,198
Closed -$135K – 1455
2024
Q3 		$135K Buy
+27,198
New +$106K 0.01% 1114
2024
Q2 		– Sell
-8,200
Closed -$34.9K – 1417
2024
Q1 		$34.9K Buy
+8,200
New +$27.3K ﹤0.01% 1370
2022
Q4 		– Sell
-3,751
Closed -$4K – 1656
2022
Q3 		$4K Hold
3,751
– – ﹤0.01% 1481
2022
Q2 		$2K Hold
3,751
– – ﹤0.01% 1622
2022
Q1 		$9K Buy
+3,751
New +$11K ﹤0.01% 1472
2021
Q4 		– Sell
-1,400
Closed -$6K – 1478
2021
Q3 		$6K Buy
+1,400
New +$5.49K ﹤0.01% 1393
2021
Q1 		– Sell
-2,783
Closed -$14K – 1389
2020
Q4 		$14K Buy
+2,783
New +$16.7K ﹤0.01% 1060

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Quantbot Technologies's AQST Position: Q2 2026 in Review

Quantbot Technologies reduced its Aquestive Therapeutics (AQST) stake by 77% in Q2 2026, selling an estimated $336K and leaving 23,707 shares worth $98.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1470.

Quantbot Technologies first reported a position in AQST in Q4 2020 and has held it in 12 quarters since. The position peaked at $429K in Q1 2026. 185 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • Quantbot Technologies held 23,707 shares of Aquestive Therapeutics worth $98.6K as of Q2 2026.
  • Quantbot Technologies sold 79,739 Aquestive Therapeutics shares in Q2 2026, an estimated $336K.
  • Aquestive Therapeutics made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1470 holding.
  • Quantbot Technologies first reported a position in Aquestive Therapeutics in Q4 2020 and has held it in 12 quarters since.
  • Quantbot Technologies's Aquestive Therapeutics position peaked at $429K in Q1 2026.
  • 185 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.